CXCR4 is a prognostic marker in acute myelogenous leukemia.

Abstract:

:CXCR4 chemokine receptors retain hematopoietic progenitors and leukemia cells within the marrow microenvironment. We prospectively evaluated the prognostic implication of CXCR4 in 90 consecutive patients with acute myelogenous leukemia (AML) by flow cytometry. Patients were divided into groups with low (n=32), intermediate (n=26), or high (n=32) CXCR4 expression, as defined by CXCR4 mean fluorescence intensity ratio thresholds of less than 5, 5 to 10, or more than 10, respectively. We found that low CXCR4 expression on AML cells correlated with a better prognosis, resulting in a longer relapse-free and overall survival of 24.3+/-2.9 months for low CXCR4-expressing patients, compared with 17.4+/-3.4 months for intermediate and 12.8+/-2 months (mean+/-SEM) for patients with high expression. In univariate analyses, CXCR4 expression, cytogenetics, white blood cell count, and serum lactate dehydrogenase (LDH) predicted for shorter survival. Multivariate analysis revealed CXCR4 expression and unfavorable cytogenetics as independent prognostic factors. We conclude that CXCR4 expression in AML is an independent prognostic predictor for disease relapse and survival that can rapidly and easily be determined at disease presentation. These findings warrant further investigation into the role of CXCR4 in AML and suggest that CXCR4 should be incorporated into the risk assessment of AML patients.

journal_name

Blood

journal_title

Blood

authors

Spoo AC,Lübbert M,Wierda WG,Burger JA

doi

10.1182/blood-2006-05-024844

subject

Has Abstract

pub_date

2007-01-15 00:00:00

pages

786-91

issue

2

eissn

0006-4971

issn

1528-0020

pii

blood-2006-05-024844

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Persistent macrocytosis assessed by erythrocyte subpopulation analysis following erythrocyte regeneration in cats.

    abstract::Serial erythrocyte volume distribution curves were used to characterize changes in erythrocyte subpopulations following the induction of Heinz body hemolytic anemia in cats. Macrocytes produced in response to hemolysis were observed after loss of reticulum. After recovery from hemolysis, a gradual reduction in mean ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weiser MG,Kociba GJ

    更新日期:1982-08-01 00:00:00

  • Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

    abstract::Here we report that a new nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse line harboring a complete null mutation of the common cytokine receptor gamma chain (NOD/SCID/interleukin 2 receptor [IL2r] gamma(null)) efficiently supports development of functional human hemato-lymphopoiesis. Purified human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0516

    authors: Ishikawa F,Yasukawa M,Lyons B,Yoshida S,Miyamoto T,Yoshimoto G,Watanabe T,Akashi K,Shultz LD,Harada M

    更新日期:2005-09-01 00:00:00

  • In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes.

    abstract::Anticoagulation with vitamin K antagonists (VKAs) is problematic because of difficulties in safely managing dosing. Polymorphisms in cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase genes (VKORC1) have been shown to affect VKA dosing in adults. The association of these polymorphisms on VKA dosing in childr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-283861

    authors: Nowak-Göttl U,Dietrich K,Schaffranek D,Eldin NS,Yasui Y,Geisen C,Mitchell LG

    更新日期:2010-12-23 00:00:00

  • Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.

    abstract::The inclusion of exon 16 in the mature protein 4.1R messenger RNA (mRNA) is a critical event in red blood cell membrane biogenesis. It occurs during late erythroid development and results in inclusion of the 10-kd domain needed for stabilization of the spectrin/actin lattice. In this study, an experimental model was e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3809

    authors: Deguillien M,Huang SC,Morinière M,Dreumont N,Benz EJ Jr,Baklouti F

    更新日期:2001-12-15 00:00:00

  • Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.

    abstract::The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers in a large series of patients with diffuse large B-cell lymphoma (DLBCL). Clinical data and tumor samples were retrieved from 12 studies from Europe and North America, with patients treated before or after the rituximab...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2011-04-345256

    authors: Salles G,de Jong D,Xie W,Rosenwald A,Chhanabhai M,Gaulard P,Klapper W,Calaminici M,Sander B,Thorns C,Campo E,Molina T,Lee A,Pfreundschuh M,Horning S,Lister A,Sehn LH,Raemaekers J,Hagenbeek A,Gascoyne RD,Weller E

    更新日期:2011-06-30 00:00:00

  • A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.

    abstract::Peripheral blood (PB) CD34+ cells from four commonly used mobilization protocols were studied to compare their phenotype and proliferative capacity with steady-state PB or bone marrow (BM) CD34+ cells. Mobilized PB CD34+ cells were collected during hematopoietic recovery after myelosuppressive chemotherapy with or wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: To LB,Haylock DN,Dowse T,Simmons PJ,Trimboli S,Ashman LK,Juttner CA

    更新日期:1994-11-01 00:00:00

  • Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells.

    abstract::Biosynthesis of leukotrienes (LTs) occurs in human myeloid cells and B lymphocytes. However, the function of leukotrienes in B lymphocytes is unclear. Here, we report that B-cell chronic lymphocytic leukemia (B-CLL) cells produce leukotriene B(4), and that specific leukotriene biosynthesis inhibitors counteracted CD40...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2546

    authors: Runarsson G,Liu A,Mahshid Y,Feltenmark S,Pettersson A,Klein E,Björkholm M,Claesson HE

    更新日期:2005-02-01 00:00:00

  • Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice.

    abstract::Multiple lines of evidence indicate that thrombopoietin (TPO) substantially impacts the number of hematopoietic stem cells and progenitors of all myeloid lineages. Nevertheless, tpo knock-out mice (T(-)) display thrombocytopenia only; blood erythroid and neutrophil levels are normal despite 60% to 85% reductions in st...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3573

    authors: Kaushansky K,Fox N,Lin NL,Liles WC

    更新日期:2002-05-15 00:00:00

  • Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.

    abstract::The LAZ3 gene encodes a novel zinc-finger protein that shares homology with several Drosophila transcription factors. This gene was identified by its disruption in translocations involving chromosome 3q27 in diffuse large-cell lymphomas. To assess the frequency and role of this gene's involvement in lymphomagenesis an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Otsuki T,Yano T,Clark HM,Bastard C,Kerckaert JP,Jaffe ES,Raffeld M

    更新日期:1995-05-15 00:00:00

  • Molecular characterization of commercial porcine factor VIII concentrate.

    abstract::Commercial porcine factor VIII concentrate (Hyate:C) is effective in treatment of patients with hemophilia A who have circulating antibodies to factor VIII. The molecular forms of factor VIII in the concentrate were identified and evaluated in light of the known properties of porcine and human factor VIII. The factor ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lollar P,Parker CG,Tracy RP

    更新日期:1988-01-01 00:00:00

  • High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

    abstract::High-dose cyclophosphamide, without stem cell rescue, has been used successfully to treat aplastic anemia and other autoimmune disorders. To determine the safety and efficacy of high-dose cyclophosphamide among patients with severe refractory autoimmune hemolytic anemia, we treated 9 patients with cyclophosphamide (50...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-01-0087

    authors: Moyo VM,Smith D,Brodsky I,Crilley P,Jones RJ,Brodsky RA

    更新日期:2002-07-15 00:00:00

  • BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair.

    abstract::Intracellular oxidative stress in cells transformed by the BCR-ABL oncogene is associated with increased DNA double-strand breaks. Imprecise repair of these breaks can result in the accumulation of mutations, leading to therapy-related drug resistance and disease progression. Using several BCR-ABL model systems, we fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-172148

    authors: Fernandes MS,Reddy MM,Gonneville JR,DeRoo SC,Podar K,Griffin JD,Weinstock DM,Sattler M

    更新日期:2009-08-27 00:00:00

  • Quantification of the locomotive behavior of polymorphonuclear leukocytes in clot preparations.

    abstract::Time-lapse videotape recordings of polymorphonuclear leukocytes (PMNs) from clot preparations were used to quantify the locomotive behavior of individual PMNs from normal subjects. Tracings derived from the videotapes allow one to quantify multiple parameters of the locomotive behavior of PMNs--direction, distance, ra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Howard TH

    更新日期:1982-05-01 00:00:00

  • Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and antitumor effects in mice.

    abstract::Personalized immunotherapy of lymphoma based on tumor idiotype (Id) has shown anti-idiotype humoral immune responses in 40%-50% and cellular immune responses in 50%-75% of follicular lymphoma patients, indicating that this therapy can be clinically successful. We have developed a novel vaccine against lymphoma consist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-355461

    authors: Carlring J,Szabo MJ,Dickinson R,De Leenheer E,Heath AW

    更新日期:2012-03-01 00:00:00

  • The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

    abstract::The present studies investigated the effects of the recently cloned flt3 ligand (FL) on the in vitro growth and differentiation of primitive and committed subsets of human CD34+ bone marrow (BM) progenitor cells. FL alone was a weak growth stimulator of CD34+ BM cells, but synergistically and directly enhanced colony ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rusten LS,Lyman SD,Veiby OP,Jacobsen SE

    更新日期:1996-02-15 00:00:00

  • Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols.

    abstract::Monitoring unfractionated heparin (UFH) is crucial to prevent over- or under-anticoagulation. However, the optimal parameters for monitoring UFH in children are not well established. The study objectives were to investigate (1) the relationship between UFH dose and its anticoagulant effect as assessed by anti-Xa, acti...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2015-06-651661

    authors: Hanslik A,Kitzmüller E,Tran US,Thom K,Karapetian H,Prutsch N,Voitl J,Michel-Behnke I,Newall F,Male C

    更新日期:2015-10-29 00:00:00

  • Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development.

    abstract::To program pluripotent cells into blood, a knowledge of the locations of precursors during their journey through the embryo and the signals they experience would be informative. The anterior (a) and posterior (p) ventral blood islands (VBIs) in Xenopus are derived from opposite sides of the pregastrula embryo. The aVB...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-081323

    authors: Walmsley M,Cleaver D,Patient R

    更新日期:2008-02-01 00:00:00

  • Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.

    abstract::Stem cell homing into the bone microenvironment is the first step in the initiation of marrow-derived blood cells. It is reported that human severe combined immunodeficient (SCID) repopulating cells home and accumulate rapidly, within a few hours, in the bone marrow and spleen of immunodeficient mice previously condit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.3283

    authors: Kollet O,Spiegel A,Peled A,Petit I,Byk T,Hershkoviz R,Guetta E,Barkai G,Nagler A,Lapidot T

    更新日期:2001-05-15 00:00:00

  • Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response.

    abstract::Stem cell factor (SCF) and interleukin-3 (IL-3) both act on several target hematopoietic populations, including mast cells. We have isolated a unique murine mast cell line, B6M, that is phenotypically similar to immature mast cells. For B6M cells, IL-3 is a survival factor and alone does not stimulate proliferation. S...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: O'Farrell AM,Ichihara M,Mui AL,Miyajima A

    更新日期:1996-05-01 00:00:00

  • Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.

    abstract::Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder, characterized by the presence of BCR/ABL fusion gene. It is unclear which cellular events drive BCR/ABL gene translocation or initiate leukemogenesis in CML. Bcl-2 promotes survival of hematopoietic stem cells. Accordingly, apoptosis-related pathw...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-169110

    authors: Kim DH,Xu W,Ma C,Liu X,Siminovitch K,Messner HA,Lipton JH

    更新日期:2009-03-12 00:00:00

  • Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.

    abstract::The novel human CC-chemokine Eotaxin is a potent and selective chemotaxin for eosinophils. Here, the biological activities and the activation profile of Eotaxin were further characterized and compared with those of other eosinophil chemotaxins such as complement fragment C5a (C5a), platelet-activating factor (PAF), an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tenscher K,Metzner B,Schöpf E,Norgauer J,Czech W

    更新日期:1996-10-15 00:00:00

  • The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells.

    abstract::The Kell blood group is one of the major antigenic systems in human red blood cells. To determine the location of the Kell gene on human chromosomes, panels containing genomic DNA of human-hamster somatic cell hybrids were hybridized with radiolabeled cDNA probe specific for the Kell locus. Only the samples containing...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee S,Zambas ED,Marsh WL,Redman CM

    更新日期:1993-05-15 00:00:00

  • Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.

    abstract::NRAS is frequently mutated in hematologic malignancies. We generated Mx1-Cre, Lox-STOP-Lox (LSL)-Nras(G12D) mice to comprehensively analyze the phenotypic, cellular, and biochemical consequences of endogenous oncogenic Nras expression in hematopoietic cells. Here we show that Mx1-Cre, LSL-Nras(G12D) mice develop an in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-280750

    authors: Li Q,Haigis KM,McDaniel A,Harding-Theobald E,Kogan SC,Akagi K,Wong JC,Braun BS,Wolff L,Jacks T,Shannon K

    更新日期:2011-02-10 00:00:00

  • Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulation.

    abstract::The BCL1 lymphoma in Balb/c mice can be successfully treated with bispecific (anti-CD3 x anti-idiotype) antibodies (BSABs). In these experiments, animals were injected intraperitoneally (IP) with 5 x 10(3) tumor cells (day 0) and treated with one single intravenous (IV) injection of 5 micrograms BSAB (day 9). Because ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Demanet C,Brissinck J,De Jonge J,Thielemans K

    更新日期:1996-05-15 00:00:00

  • Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.

    abstract::The tal-1 gene encodes a basic helix-loop-helix (bHLH) transcription factor required for primitive and definitive hematopoiesis. Additionally, ectopic activation of the tal-1 gene during T lymphopoiesis occurs in numerous cases of human T-cell acute lymphoblastic leukemia. With the use of transgenic mice, we show that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.2.491

    authors: Goardon N,Schuh A,Hajar I,Ma X,Jouault H,Dzierzak E,Roméo PH,Maouche-Chrétien L

    更新日期:2002-07-15 00:00:00

  • Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood.

    abstract::A patient with recurrent pulmonary abscess, weight loss, and alcoholism was found to have extremely high serum vitamin B12 and unsaturated vitamin B12-binding capacity (UBBC) levels. While transcobalamin (TC) II was also increased, most of his UBBC was due to an abnormal binding protein which carried greater than 80% ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carmel R,Tatsis B,Baril L

    更新日期:1977-06-01 00:00:00

  • Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.

    abstract::Several lines of evidence indicate that macrophage inflammatory protein-1alpha (MIP-1alpha) modulates the proliferation of hematopoietic progenitor cells, depending on their maturational stages. To clarify the mechanisms for the modulation of hematopoiesis by this chemokine, we examined the expression of a receptor fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Su S,Mukaida N,Wang J,Zhang Y,Takami A,Nakao S,Matsushima K

    更新日期:1997-07-15 00:00:00

  • Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro.

    abstract::Recombinant gibbon interleukin-3 (IL-3) is a multilineage hematopoietic colony-stimulating factor (CSF) that recently was cloned and found to be highly homologous with human IL-3. Gibbon IL-3, as well as human granulocyte-CSF (G-CSF) and human granulocyte-macrophage CSF (GM-CSF), stimulated normal human bone marrow ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Paquette RL,Zhou JY,Yang YC,Clark SC,Koeffler HP

    更新日期:1988-06-01 00:00:00

  • Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells.

    abstract::Activated ras genes are often associated with human myeloid leukemias with a monocytic differentiated phenotype. To investigate the role of the activated ras gene in leukemogenesis, a myeloid nontumorigenic cell line (FDC-P1) was infected with a selectable retroviral vector carrying the v-Ha-ras gene (H1neo). Infected...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hibi S,Löhler J,Friel J,Stocking C,Ostertag W

    更新日期:1993-04-01 00:00:00

  • Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.

    abstract::Over the past few years, substantial advances have been made in understanding the pathogenesis, evolution, and complexity of mast cell neoplasms. New diagnostic and prognostic parameters and novel therapeutic targets with demonstrable clinical impact have been identified. Several of these new markers, molecular target...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-731893

    authors: Valent P,Akin C,Metcalfe DD

    更新日期:2017-03-16 00:00:00